J&J | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
AbbVie USD 3.29B 562M 2025-03
Abbott USD 3.05B 144M 2025-03
Amgen USD 1.88B 253M 2024-12
AstraZeneca USD 3.59B 1.96B 2025-03
Baxter International USD 615M 16M 2024-12
Bayer EUR 4.34B 610M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Biogen USD 677.3M 99.6M 2024-12
Boston Scientific USD 1.6B 15M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
CONMED USD 123.97M 33.04M 2024-12
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 465.7M 26.2M 2025-03
Eli Lilly USD 2.42B 324.7M 2024-12
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Globus Medical USD 253.48M 12.74M 2024-12
Hologic USD 265M 15.8M 2024-12
Indivior 132M 179M 2025-03
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 563.4M 49.2M 2025-03
J&J USD 5.11B 1.34B 2025-03
Medtronic USD 2.72B 34M 2025-01
Merck USD 2.53B 319M 2025-03
Merit Medical Systems USD 107.49M 4.91M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 105.84M 6.2M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12
Zoetis USD 625M 60M 2024-12



J&J Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.